JPS5665819A - Composition for mefenamic acid pharmaceutical - Google Patents

Composition for mefenamic acid pharmaceutical

Info

Publication number
JPS5665819A
JPS5665819A JP14083179A JP14083179A JPS5665819A JP S5665819 A JPS5665819 A JP S5665819A JP 14083179 A JP14083179 A JP 14083179A JP 14083179 A JP14083179 A JP 14083179A JP S5665819 A JPS5665819 A JP S5665819A
Authority
JP
Japan
Prior art keywords
fatty acid
acid
mefenamic acid
mefenamic
ester
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP14083179A
Other languages
Japanese (ja)
Inventor
Hiroshi Otsuka
Kotaro Yasuda
Yasunori Morimoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MEDEISERU KENKYUSHO KK
Original Assignee
MEDEISERU KENKYUSHO KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MEDEISERU KENKYUSHO KK filed Critical MEDEISERU KENKYUSHO KK
Priority to JP14083179A priority Critical patent/JPS5665819A/en
Publication of JPS5665819A publication Critical patent/JPS5665819A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicinal Preparation (AREA)

Abstract

PURPOSE: The titled composition useful as an anti-inflammatory and analgesic agent, capable of accelerating the absorption through a digestive tract and suppressing the side effect, and comprising mefenamic acid, specific amounts of sorbitan fatty acid ester of polyoxyethylene and sucrose ester of a fatty acid.
CONSTITUTION: Mefenamic acid (fine powder of particle size ≤74μ) is incorporated with sorbitan fatty acid ester of polyoxyethylene, e.g. lauric or oleic acid having an HLB of 8W15, and sucrose ester of a fatty acid, e.g. palmitic, stearic or lauric acid having an HLB of 5W14, to give a composition. The mixing weight ratio of the mefenamic acid to the esters of the fatty acid is preferably 1:0.4W1:0.7. The two types of fatty acid esters will not reduce the drug action even in the case of the mefenamic acid in an amount 1/2 the conventional one. Thus, the dose can be reduced to suppress side effects, e.g. gastroenteric trouble.
COPYRIGHT: (C)1981,JPO&Japio
JP14083179A 1979-10-31 1979-10-31 Composition for mefenamic acid pharmaceutical Pending JPS5665819A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP14083179A JPS5665819A (en) 1979-10-31 1979-10-31 Composition for mefenamic acid pharmaceutical

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP14083179A JPS5665819A (en) 1979-10-31 1979-10-31 Composition for mefenamic acid pharmaceutical

Publications (1)

Publication Number Publication Date
JPS5665819A true JPS5665819A (en) 1981-06-03

Family

ID=15277726

Family Applications (1)

Application Number Title Priority Date Filing Date
JP14083179A Pending JPS5665819A (en) 1979-10-31 1979-10-31 Composition for mefenamic acid pharmaceutical

Country Status (1)

Country Link
JP (1) JPS5665819A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60185714A (en) * 1983-11-17 1985-09-21 ヘルムツト オペル Surface analgesic and inflammatory
JPH023609A (en) * 1988-06-21 1990-01-09 Fujimoto Seiyaku Kk Long-acting drug preparation containing nicardipine hydrochloride as active component
JP2013501062A (en) * 2009-08-03 2013-01-10 エミスフィアー テクノロジーズ インコーポレイテッド Rapid-acting naproxen composition with reduced gastrointestinal effects

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53133624A (en) * 1977-04-25 1978-11-21 Dai Ichi Seiyaku Co Ltd Highly soluble rifamplicin solid preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS53133624A (en) * 1977-04-25 1978-11-21 Dai Ichi Seiyaku Co Ltd Highly soluble rifamplicin solid preparation

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60185714A (en) * 1983-11-17 1985-09-21 ヘルムツト オペル Surface analgesic and inflammatory
JPH023609A (en) * 1988-06-21 1990-01-09 Fujimoto Seiyaku Kk Long-acting drug preparation containing nicardipine hydrochloride as active component
JP2013501062A (en) * 2009-08-03 2013-01-10 エミスフィアー テクノロジーズ インコーポレイテッド Rapid-acting naproxen composition with reduced gastrointestinal effects

Similar Documents

Publication Publication Date Title
MX9404762A (en) COMPOSITIONS FOR INHALATION AND PROCESS FOR ITS PREPARATION.
JPS55153715A (en) Prolonged granule of theophylline
IE43083L (en) Sustained release formulations
JPS5659710A (en) Preventive and remedy for psoriasis
JPS5665819A (en) Composition for mefenamic acid pharmaceutical
DE3665668D1 (en) Pharmaceutical granulate containing ambroxol or bromohexine
HUT75230A (en) Novel pharmaceutical composition for the preparation of a stable powder containing an active principle comprising an association of acetylsalicylic acid and metoclopramide
JPS5781409A (en) External plaster
NZ183398A (en) High solid content ultravidet curable compositions: mixture of poly and mono ethyenically unsaturated ester polyether compounds
JPS5350316A (en) Drug composition for oral administration
JPS5770815A (en) Absorption improver
JPS56164750A (en) Antifoaming agent for food
JPS56145223A (en) Drug composition
JPS5686114A (en) Pharmaceutical composition for suppository
JPS5484020A (en) Composition for coating medicine and method for coating the same
JPS56166108A (en) Base for cosmetic and medicine
JPS567720A (en) Antiphlogistic agent
JPS56131344A (en) Preparation of foaming fat or oil for cake
JPS5616408A (en) Composition for drug
JPS5793914A (en) Stabilizing method of scopolia root extract in pharmaceutical
JPS5640606A (en) Preparation of stable drug
JPS52130905A (en) Medicinal composition
GB1147731A (en) Improvements relating to the stabilization of chlormethiazole
JPS55133316A (en) Antilipemic agent
JPS537846A (en) Combustion apparatus